← Back to catalogue

Dario Blood Glucose Monitoring System

FDA UDI

by Labstyle Innovation Ltd

Identity

Trade Name
Dario Blood Glucose Monitoring System FDA UDI
Generic Name
Home-use/point-of-care blood glucose/blood pressure monitoring system FDA UDI
Device Name
The Dario Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home to monitor the effectiveness of diabetes control. FDA UDI
Model / Reference
1015-01 FDA UDI
Description
The Dario Blood Glucose Monitoring System is intended for self-testing outside the body (in vitro diagnostic use) by people with diabetes at home to monitor the effectiveness of diabetes control. FDA UDI

Identifiers

Primary DI / UDI-DI
00850065006000 FDA UDI
510(k) Number
K150817 FDA UDI
GMDN Term
Home-use/point-of-care blood glucose/blood pressure monitoring system FDA UDI

Classification

Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Home-use/point-of-care blood glucose/blood pressure monitoring system

Dario Blood Glucose Monitoring System by Labstyle Innovation Ltd — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Home-use/point-of-care blood glucose/blood pressure monitoring system.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 93ff127e-4611-4321-8b8c-9b6f0d14ff1a 34 fields · synced May 30, 2026